WAVERLEY PHARMA INC (WAVE.CA) Stock Income Statement
TSX-V:WAVE - TSX Venture Exchange - CA94357L1058 - Common Stock - Currency: CAD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 475.40K | 412.10K | 1.25M | 1.75M | 1.38M | |||
| Cost Of Goods | 261.30K | 332.30K | 963.00K | 1.53M | 1.19M | |||
| Gross Profit | 214.00K | 79.80K | 283.80K | 222.70K | 181.70K | |||
| Operating Expenses | 1.06M | 1.36M | 1.22M | 1.01M | 995.50K | |||
| Research and Development | 423.70K | 234.60K | 81.70K | 53.80K | 53.40K | |||
| Selling, General, and Administrative Expenses | 613.30K | 806.20K | 1.14M | 955.70K | 942.10K | |||
| Operating Income | -846.50K | -1.28M | -936.20K | -786.80K | -813.80K | |||
| Interest Income/Expense | -202.60K | -77.20K | -25.90K | -51.70K | -7.90K | |||
| Other Income/Expense | 117.40K | 78.60K | 298.00K | 42.00K | 11.80K | |||
| Non Recurring Items | -15.50K | -942.60K | N/A | N/A | 104.20K | |||
| Income Before Taxes | -947.10K | -2.22M | -664.10K | -796.50K | -705.80K | |||
| Net Income | -947.10K | -2.22M | -664.10K | -796.50K | -705.80K | |||
| EBITDA | -822.50K | -960.90K | -828.50K | -758.60K | -805.60K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.02 | -0.04 | -0.01 | -0.01 | -0.01 | |||
| Statistics | ||||||||
| Gross Profit Margin | 45.01% | 19.36% | 22.76% | 12.70% | 13.21% | |||
| Profit Margin | -199.22% | -539.70% | -53.26% | -45.44% | -51.33% | |||
| Operating Profit Margin | -178.06% | -311.28% | -75.09% | -44.89% | -59.18% | |||
All data in CAD